Development of a risk scoring system for patients with papillary thyroid cancer

As the importance of personalized therapeutics in aggressive papillary thyroid cancer (PTC) increases, accurate risk stratification is required. To develop a novel prognostic scoring system for patients with PTC (n = 455), we used mRNA expression and clinical data from The Cancer Genome Atlas. We pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pak, Kyoungjune, Kim, Yun Hak, Suh, Sunghwan, Goh, Tae Sik, Jeong, Dae Cheon, Kim, Seong Jang, Kim, In Joo, Han, Myoung‐Eun, Oh, Sae‐Ock
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433682/
https://www.ncbi.nlm.nih.gov/pubmed/30729678
http://dx.doi.org/10.1111/jcmm.14208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433682/
https://www.ncbi.nlm.nih.gov/pubmed/30729678
http://dx.doi.org/10.1111/jcmm.14208

Ejemplares similares